Bioventix plc
("Bioventix" or the "Company")
Director/PDMR Shareholdings and Issue of Equity
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, was notified on 18 May 2023 of the following transactions in its ordinary shares of 5 pence each ("Ordinary Shares"):
| Director | Role | Options over Ordinary Shares exercised | Ordinary Shares sold | Average sale price per Ordinary Share | Ordinary Shares subsequently held | Percentage of issued share capital subsequently held |
| Ian Nicholson | Non-Executive Chairman | 1,638 | 1,638 | 3,651.53 | 13,000 | 0.2% |
The options over Ordinary Shares ("Options") were exercised at a price of 1350 pence per Ordinary Share pursuant to the Company's 2013 EMI Share Option Scheme, details of which can be found at www.bioventix.com. In addition, a current employee exercised 2,333 Options.
Issue of Equity
The Company has applied for 3,971 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur and that dealings will commence in the new Ordinary Shares on 25 May 2023. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be 5,219,656 and the Company holds no shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 5,219,656.
The above figure of 5,219,656 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Bioventix under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
| Bioventix plc Peter Harrison Bruce Hiscock |
Chief Executive Officer Chief Financial Officer | Tel: 01252 728 001 |
| | | |
| finnCap Ltd Geoff Nash/Simon Hicks Alice Lane |
Corporate Finance ECM | Tel: 020 7220 0500 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA") | |||||
| a) | Name | Ian Nicholson | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Chairman | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Bioventix plc | ||||
| b) | LEI | 213800225MHX7LZQY108 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each | ||||
| Identification code | GB00B4QVDF07 | |||||
| b) | Nature of the transaction | Exercise of Options over Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price | See 4(c) | ||||
| e) | Date of the transaction | 18 May 2023 | ||||
| f) | Place of the transaction | Off market transaction | ||||
| 1 | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA") | |||||
| a) | Name | Ian Nicholson | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Chairman | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Bioventix plc | ||||
| b) | LEI | 213800225MHX7LZQY108 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each | ||||
| Identification code | GB00B4QVDF07 | |||||
| b) | Nature of the transaction | Sale of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price | See 4(c) | ||||
| e) | Date of the transaction | 18 May 2023 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON)
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
